Research Projects & Grants

For Profit Organization

  • A phase III double-blind, randomized, placebo-controlled study assessing the efficacy, safety and tolerability of Idebenone in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids (SNT-II-012), Role: Investigator, Santhera Pharmaceuticals (Switzerland) limited, (06/2020 - 06/2021) Status: Completed
  • A phase III open-label extension study to assess the long-term safety and efficacy of Idebenone in patients with Duchenne Muscular Dystrophy (DMD) who completed the SIDEROS study, Role: Investigator, Santhera Pharmaceuticals (Switzerland) limited, (06/2020 - 06/2021) Status: Completed